(Total Views: 410)
Posted On: 07/24/2024 8:19:42 PM
Post# of 148878
MJS719, & why not LL AAV for other diseases too, down the distant road?
Others are working on AAV for certain diseases, but they still have the obvious -- side effect issues.
Dr. Sacha continues getting "provocative" results, i don't see how industry interests dosen't push LL beyond the HIV work.
But absolutely, finding combo(s) for LL & the future of "functional cure", could also see LL as a dominant drug baseline for R&D & frwd .......
Others are working on AAV for certain diseases, but they still have the obvious -- side effect issues.
Dr. Sacha continues getting "provocative" results, i don't see how industry interests dosen't push LL beyond the HIV work.
But absolutely, finding combo(s) for LL & the future of "functional cure", could also see LL as a dominant drug baseline for R&D & frwd .......
(5)
(0)Scroll down for more posts ▼
